Home Page
References OMIM Gene GeneReviews HGMD HGNC
GENATLAS PHENOTYPE
last update : 03-11-2015
Symbol ASB
Location Xp11.21
Name anemia, sideroblastic
Other name(s)
  • anemia, sideroblastic, X-linked
  • Corresponding gene ALAS2
    Other symbol(s) XLSA
    Main clinical features
  • early onset with variable pyridoxine responsiveness, also late onset with constant pyridoxine responsiveness
  • hypochromic microcytic anemia with 2 discrete populations of red blood cells, one microcytic and the other normocytic, marrow ringed sideroblasts, particularly prominent in the late erythroid precursors, and systemic iron overload secondary to chronic ineffective erythropoiesis
  • severity of the disorder (neonatal to late onset) depends primarily on the amount of residual ALAS2 mitochondrial enzyme activity (PMID: 22740690))
  • Genetic determination sex linked
    Function/system disorder hematology
    Type disease
    Gene product
    Name aminolevulinate, delta-synthase 2, erythroid (ALAS2)
    Remark(s)
  • exon 11-encoded ALAS2 mutations cause loss of binding to SUCLA2 and heme deficiency in XLSA patients (PMID: 22740690))